#U.S. Companion Animal Health Market size

[luckydige45]

According to Nova One Advisor, the U.S. companion animal health market size was exhibited at USD 13.19 billion in 2023 and is projected to hit around USD 28.32 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2024 to 2033.

[distinguishedruinsfart]

Animal Sedatives Market Analysis: Supply Chain, Pricing, and Forecast 2031

Animal Sedatives Market Growth,  Demand and Forecast 2031  

The Animal Sedatives Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2031. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Brief Overview of the Animal Sedatives Market:

The global Animal Sedatives Market is expected to experience substantial growth between 2024 and 2031. Starting from a steady growth rate in 2023, the market is anticipated to accelerate due to increasing strategic initiatives by key market players throughout the forecast period.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-animal-sedatives-market

Which are the top companies operating in the Animal Sedatives Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This Global Animal Sedatives Market report provides the information of the Top Companies in Animal Sedatives Market in the market their business strategy, financial situation etc.

Zoetis Inc. (U.S.), Boehringer Ingelheim Animal Health (Germany), Merck Animal Health (U.S.), Bayer Animal Health (Germany), Elanco Animal Health (U.S.), Ceva Santé Animale (France), Vetoquinol (France), Norbrook Laboratories (U.K.), Virbac (France), and Dechra Pharmaceuticals (U.K.) e

Report Scope and Market Segmentation

Which are the driving factors of the Animal Sedatives Market?

The driving factors of the Animal Sedatives Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

Animal Sedatives Market - Competitive and Segmentation Analysis:

**Segments**

- **Type:** The animal sedatives market can be segmented into pharmaceutical sedatives and natural sedatives. Pharmaceutical sedatives are synthetic drugs that are commonly used in veterinary practices, while natural sedatives are derived from plant extracts and herbal sources. - **Application:** The market can also be segmented based on application, including segments such as surgery, diagnostic procedures, advanced imaging, and others. Animal sedatives are utilized across various medical procedures to ensure the safety and comfort of animals. - **Animal Type:** Furthermore, the market can be segmented by animal type, such as companion animals, livestock animals, and exotic animals. Different types of animals may have varying requirements when it comes to sedation, leading to the need for specialized products.

**Market Players**

- **Merck & Co., Inc.:** A leading player in the animal healthcare industry, Merck offers a wide range of pharmaceutical products, including animal sedatives, to cater to the needs of veterinarians and pet owners. - **Zoetis:** Another prominent company in the market, Zoetis specializes in providing comprehensive animal health solutions, which also include sedatives for different animal species. - **Boehringer Ingelheim International GmbH:** With a focus on research and innovation, Boehringer Ingelheim develops advanced pharmaceutical products, including animal sedatives, to enhance animal well-being during various medical procedures. - **Virbac:** Virbac is known for its high-quality animal health products, including sedatives, that are designed to meet the specific requirements of veterinarians and pet owners worldwide.

The global animal sedatives market is witnessing significant growth as the demand for veterinary care continues to rise. Factors such as increasing pet ownership, growing awareness about animal health, and advancements in veterinary medicine are driving market expansion. Pharmaceutical sedatives dominate the market due to their effectiveness and wide availability, especially for companion animals undergoing surgeries and diagnostic procedures. Additionally, the trend towards natural and herbal sedatives is gaining traction, as pet ownersThe global animal sedatives market is experiencing steady growth driven by several key factors. One of the primary drivers is the increasing pet ownership worldwide, which translates to a higher demand for veterinary care services and products, including sedatives. As more households embrace pets as members of the family, there is a growing emphasis on ensuring the health and well-being of these animals, leading to a rise in medical procedures that may require sedation. Moreover, the rising awareness about animal health and welfare among pet owners and veterinarians is also contributing to the expansion of the animal sedatives market.

Pharmaceutical sedatives continue to dominate the market due to their proven efficacy and widespread availability in veterinary practices. These synthetic drugs are often preferred for their predictable effects and precise dosing, making them suitable for surgeries, diagnostic procedures, and other medical interventions in animals. Additionally, pharmaceutical sedatives are typically backed by extensive research and clinical trials, providing reassurance to veterinarians and pet owners regarding their safety and efficacy.

In recent years, there has been a notable trend towards the use of natural sedatives derived from plant extracts and herbal sources. This shift can be attributed to the growing consumer preference for natural and holistic healthcare solutions for animals, mirroring similar trends in the human healthcare industry. Natural sedatives are perceived as safer alternatives to synthetic drugs by some pet owners, particularly those concerned about potential side effects and long-term health implications. As a result, manufacturers in the animal sedatives market are increasingly incorporating natural ingredients into their product offerings to cater to this evolving demand.

The segmentation of the animal sedatives market by animal type is also driving market dynamics, as different species may require specific sedation protocols tailored to their physiological characteristics and health needs. Companion animals, such as dogs and cats, are among the primary recipients of sedatives for various medical procedures, including surgeries, dental cleanings, and grooming sessions. Livestock animals, including cows, pigs, and sheep, may also require sedation for procedures like castrations,**Market Players**

- Zoetis Inc. (U.S.) - Boehringer Ingelheim Animal Health (Germany) - Merck Animal Health (U.S.) - Bayer Animal Health (Germany) - Elanco Animal Health (U.S.) - Ceva Santé Animale (France) - Vetoquinol (France) - Norbrook Laboratories (U.K.) - Virbac (France) - Dechra Pharmaceuticals (U.K.)

The global animal sedatives market is experiencing steady growth, driven by various factors such as increasing pet ownership, growing awareness about animal health, and advancements in veterinary medicine. The demand for veterinary care services and products, including sedatives, is on the rise as more households consider pets as integral members of the family. This trend translates into a higher need for medical procedures that may require sedation to ensure the well-being of animals. The market is predominantly led by pharmaceutical sedatives due to their effectiveness and wide availability, particularly for companion animals undergoing surgeries and diagnostic procedures. Natural sedatives derived from plant extracts and herbal sources are also gaining popularity as pet owners show a preference for natural and holistic healthcare solutions for their animals.

The animal sedatives market segmentation by animal type plays a crucial role in shaping market dynamics. Different animal species have unique sedation requirements based on their physiological characteristics and medical needs. Companion animals like dogs and cats often require sedatives for procedures ranging from surgeries to grooming sessions. Livestock animals such as cows, pigs, and sheep

North America, particularly the United States, will continue to exert significant influence that cannot be overlooked. Any shifts in the United States could impact the development trajectory of the Animal Sedatives Market. The North American market is poised for substantial growth over the forecast period. The region benefits from widespread adoption of advanced technologies and the presence of major industry players, creating abundant growth opportunities.

Similarly, Europe plays a crucial role in the global Animal Sedatives Market, expected to exhibit impressive growth in CAGR from 2024 to 2031.

Explore Further Details about This Research Animal Sedatives Market Report https://www.databridgemarketresearch.com/reports/global-animal-sedatives-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.

Neutral perspective on the Animal Sedatives Market scenario

Recent industry growth and new developments

Competitive landscape and strategies of key companies

The Historical, current, and estimated Animal Sedatives Market size in terms of value and size

In-depth, comprehensive analysis and forecasting of the Animal Sedatives Market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2031) of the following regions are covered in Chapters

The countries covered in the Animal Sedatives Market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of the Middle East and Africa

Detailed TOC of Animal Sedatives Market Insights and Forecast to 2031

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Animal Sedatives Market Landscape

Part 05: Pipeline Analysis

Part 06: Animal Sedatives Market Sizing

Part 07: Five Forces Analysis

Part 08: Animal Sedatives Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Animal Sedatives Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse More Reports:

https://www.databridgemarketresearch.com/jp/reports/global-animal-sedatives-market

https://www.databridgemarketresearch.com/zh/reports/global-animal-sedatives-market

https://www.databridgemarketresearch.com/ar/reports/global-animal-sedatives-market

https://www.databridgemarketresearch.com/pt/reports/global-animal-sedatives-market

https://www.databridgemarketresearch.com/de/reports/global-animal-sedatives-market

https://www.databridgemarketresearch.com/fr/reports/global-animal-sedatives-market

https://www.databridgemarketresearch.com/es/reports/global-animal-sedatives-market

https://www.databridgemarketresearch.com/ko/reports/global-animal-sedatives-market

https://www.databridgemarketresearch.com/ru/reports/global-animal-sedatives-market

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 1680

Email:- corporatesales@databridgemarketresearch.com

[global-research-report]

Future of Veterinary Care: Companion Animal Medicine Market Insights and Projections for 2030

The global companion animal medicine market size is expected to reach USD 41.18 billion by 2030 and is expected to expand at 9.9% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the growth of the market for companion animal medicine include the rising pet population, the increased prevalence of diseases, and the availability of pet insurance.

In Canada for example, more than half of the country’s households (around 60% of households) owned at least one dog or cat in 2022, according to the Canadian Animal Health Institute (CAHI). The country’s dog population increased from 7.7 million in 2020 to 7.9 million in 2022, whereas the cat population increased from 8.1 million in 2020 to 8.5 million in 2022. CAHI also reported a surge in feline vet visits following the start of the COVID-19 outbreak in 2020.

The COVID-19 pandemic notably affected the market for companion animal medicine. The impact included dampened sales, supply chain challenges, operational hurdles, falling inpatient visits, and reduced demand. Elanco for instance reported a 20% decline in revenue during Q2 2020. The company’s companion animal segment, in particular, was adversely impacted by the fall in brands in international markets and those administered in the clinic e.g. vaccines.

The company reported a recovery in sales during H2 2020. Vetoquinol on the other hand reported an increase in sales, driven by its essential portfolio including veterinary drugs in 2020 despite limited access to vet clinics and hospitals due to lockdown protocols. Boehringer Ingelheim too registered increased sales in the companion animal segment.

With the rising number of pets across the globe, the trend of pet humanization has gained traction in several key markets. Pet guardians are becoming increasingly aware of their pet’s health, treatment, and well-being. This has increased the adoption of pet insurance to reduce the financial risks for them. Petplan- the largest pet insurance provider in the U.K. offers insurance policies for various species including dogs, cats, horses, small mammals, birds, reptiles, rabbits, and multi-pet owners. These policies provide coverage for physical and online consultations, prescription medicine, diagnostic tests, surgery, dental injury, cancer treatment, and more.

The rising prevalence of diseases in pets is another key driver expected to contribute to market growth. Parasitic infections from internal and external parasites for example, commonly affect pets. Antibiotics and topical therapies are often prescribed in the case of pyoderma. However, further testing and routine bathing with medicated shampoos may be prescribed in case of chronic or recurring pyoderma. For example, Viv Silky Shampoo by Vivaldis is indicated for various fungal and bacterial infections including superficial and deep pyoderma.

Companion Animal Medicine Market Report Highlights

The companion animal medicine industry was valued at USD 19.51 billion in 2022. It is further projected to grow at a CAGR of 9.9% during the forecast period

Growing R&D initiatives by major companies are estimated to be a key driver for the market. Pet humanization is further contributing to increased expenditure on pets including pet medicines

According to APPA, U.S. citizens spent about USD 34.3 billion on vet care and products in 2021. The category included expenditure on routine veterinary care, surgical procedures, and pharmaceuticals

Based on animal type, the dog segment dominated the market with nearly 45% revenue share in 2022 owing to the large preference for dogs as pets and the rising prevalence of canine diseases

The hospital pharmacy segment dominated the market by distribution channel in 2022. The factors contributing to the large share include higher patient footfalls at hospitals and the convenience of buying the necessary medications as soon as the pet is diagnosed

North America region dominated the market in 2022 and registered the largest revenue share of over 36%. This is due to the region’s high per capita animal healthcare spending and a large number of pet owners

In Asia Pacific, the market is expected to grow at the fastest rate of over 10.4% CAGR due to the rising pet population and pet health awareness

Companion Animal Medicine Market Segmentation

Grand View Research has segmented the global companion animal medicine market based on animal type and region:

Companion Animal Medicine Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

Dogs

By Product

Biologics

Vaccines

By Type

Attenuated Live Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid

Others

By Indication

Distemper

Kennel cough (Parainfluenza)

Parvovirus

Canine herpes

Lyme Disease

Rabies

Others

Pharmaceuticals

Parasiticides

Anti-infectives

Anti-inflammatory

Analgesics

Others

Medicated Feed Additives

By Indication

Infectious Diseases

Dermatologic Diseases

Pain

Orthopedic Diseases

Behavioral Diseases

Other Indications

By Distribution Channel

Retail

E-commerce

Hospital Pharmacy

Cats

By Product

Biologics

Vaccines

By Type

Attenuated Live Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid

Others

By Indication

Rhinotracheitis

Calicivirus

Coronavirus

Panleukopenia

Rabies

Others

Pharmaceuticals

Parasiticides

Anti-infectives

Anti-inflammatory

Analgesics

Others

Medicated Feed Additives

By Indication

Infectious Diseases

Dermatologic Diseases

Pain

Orthopedic Diseases

Behavioral Diseases

Other Indications

By Distribution Channel

Retail

E-commerce

Hospital Pharmacy

Horses

By Product

Biologics

Vaccines

Attenuated Live Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid

Others

Others

Pharmaceuticals

Parasiticides

Anti-infectives

Anti-inflammatory

Analgesics

Others

Medicated Feed Additives

By Indication

Infectious Diseases

Dermatologic Diseases

Pain

Orthopedic Diseases

Behavioral Diseases

Other Indications

By Distribution Channel

Retail

E-commerce

Hospital Pharmacy

Other Companion Animals

By Product

Biologics

Vaccines

Attenuated Live Vaccines

Inactivated Vaccines

Recombinant Vaccines

Toxoid

Others

Others

Pharmaceuticals

Parasiticides

Anti-infectives

Anti-inflammatory

Analgesics

Others

Medicated Feed Additives

By Indication

Infectious Diseases

Dermatologic Diseases

Pain

Orthopedic Diseases

Behavioral Diseases

Other Indications

By Distribution Channel

Retail

E-commerce

Hospital Pharmacy

Companion Animal Medicine Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

Japan

China

India

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East & Africa

South Africa

Saudi Arabia

Rest of MEA

List of Key Players

Merck & Co., Inc.

Ceva

Vetoquinol S.A.

Zoetis

Boehringer Ingelheim International GmbH

Elanco

Virbac

Bimeda, Inc.

Norbrook

Calier

Order a free sample PDF of the Companion Animal Medicine Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Veterinary Oncology Market Size, Share And Trends Analysis Report

The global veterinary oncology market size is expected to reach USD 3.11 billion in 2030 and is projected to grow at a CAGR of 12.08% from 2025 to 2030. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.

Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.

Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals. 

Gather more insights about the market drivers, restrains and growth of the Veterinary Oncology Market

Veterinary Oncology Market Report Highlights

• Increasing prevalence of cancer in companion animals, several clinical trial studies to evaluate the safety and effectiveness of cancer therapeutics for pets and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market.

• Chemotherapy accounted for the largest revenue share over the coming years, owing to its increasing adoption for pet cancer treatment either alone or in combination with other therapies.

• The canine segment held the largest revenue share of over 86.09% in 2024, increasing the population of dogs and high prevalence of cancer in dogs as compared to cats.

• North America held the dominant share as of 2024, due to the favorable government policies, new product launch by the companies, and huge investment for veterinary oncology treatment.

• Asia Pacific is anticipated to witness lucrative growth due to increasing focus on animal health and expenditure, increasing number of pet population being exposed to cancer, government focus on animal safety, and several initiatives to curb cancer cases in pet animals.

Veterinary Oncology Market Segmentation

Grand View Research has segmented the global Veterinary Oncology market report based on product, type of waste, end use, and region:

Veterinary Oncology Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Canine

• Feline

• Equine

Veterinary Oncology Therapy Outlook (Revenue, USD Million, 2018 - 2030)

• Radiotherapy 

o Stereotactic Radiation Therapy

o LINAC

o Other Types

o Conventional Radiation Therapy

o Surgery

o Chemotherapy

o Immunotherapy

o Other Therapies

Veterinary Oncology Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)

• Skin Cancers

• Lymphomas

• Sarcomas

• Others

Veterinary Oncology Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

o Rest of EU

• Asia Pacific

o Japan

o China

o India

o Australia

o South Korea

o Thailand

o Rest of APAC

• Latin America

o Brazil

o Argentina

o Rest of LA

• Middle East and Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

o Rest of MEA

Order a free sample PDF of the Veterinary Oncology Market Intelligence Study, published by Grand View Research.

[dtgmarketreport]

Pet Pharmaceuticals Market Size, Share & Forecast 2025-2035

Industry Outlook for the Pet Pharmaceuticals Market

The pet pharmaceuticals market is witnessing significant growth, driven by increasing pet ownership and heightened awareness of animal health and wellness. Valued at USD 13.2 billion in 2024, the market is projected to reach USD 30.3 billion by 2035, growing at a CAGR of 7.85% between 2025 and 2035. This growth reflects the broader commitment of pet owners and the industry to enhancing the quality of life for companion animals.

Key Market Dynamics

Growing Pet Ownership and Awareness

The rise in global pet ownership has significantly boosted the demand for veterinary care and pharmaceuticals. Pet owners today are more invested in preventive healthcare, mirroring trends in human health. This has led to the development and adoption of advanced veterinary medicines and treatments.

Innovations in Veterinary Medicine

Advancements in veterinary science, including genetic testing and personalized medicine, are driving the market forward. Customized treatments based on genetic predispositions are becoming more prevalent, offering targeted care for specific pet needs. For example, over 60% of pet owners in the U.S. now seek personalized healthcare solutions for their animals.

Expansion of Online Pharmacies

The rise of e-commerce and online veterinary pharmacies has made pet medications more accessible. This shift has also enabled faster consultations through telemedicine, improving diagnosis and treatment timelines. Pharmaceutical companies are leveraging this trend to reach a digitally savvy customer base.

Challenges in Cost and Accessibility

Despite its growth, the market faces barriers in the form of high veterinary care costs. Routine check-ups, medications, and specialized treatments often prove expensive, deterring some pet owners from seeking necessary care. This financial strain underscores the need for affordable healthcare solutions.

Request sectional data : https://www.metatechinsights.com/industry-insights/pet-pharmaceuticals-market-1173

Segment Analysis

By Pet Type

Dogs dominate the market due to their higher ownership rates and susceptibility to various illnesses. This drives demand for anti-infectives, pain relievers, and other medications.

Other segments, including cats and small animals, are growing steadily as awareness of their health needs increases.

By Product Type

Anti-infectives lead the market, addressing a wide range of infections.

Vaccines, anti-inflammatory drugs, and parasiticides also hold significant market shares as preventive care gains traction.

By Therapeutic Area

Oncology is an emerging segment due to the increasing prevalence of cancer in pets. Advanced therapies like immunotherapy and targeted treatments are gaining momentum.

Dermatology and orthopedic care are also key areas, driven by conditions such as arthritis and skin disorders in aging pets.

By Route of Administration

Medications are available in diverse formats, including oral, injectable, and topical options, catering to different pet needs and owner preferences.

By Distribution Channel

Veterinary hospitals and clinics remain the primary distribution channels.

However, online pharmacies are rapidly growing, offering convenience and affordability.

Regional Insights

North America

North America is the largest market, driven by high pet ownership and substantial spending on pet healthcare.

The U.S. leads in innovation, with robust regulatory support for drug approvals and the growth of e-commerce platforms.

Asia Pacific

The Asia Pacific is the fastest-growing market, fueled by rising disposable incomes and urbanization. Countries like China and India are seeing a surge in pet ownership, while Australia and New Zealand maintain steady growth due to established veterinary practices.

Regulatory challenges and price sensitivity persist, but overall trends are promising.

Europe

Europe shows steady growth, with countries like Germany, France, and the U.K. investing in advanced veterinary care.

Latin America and the Middle East & Africa

These regions are growing as awareness of pet health increases. The expansion of e-commerce is helping improve access to veterinary products.

Opportunities and Challenges

Opportunities

1. Personalized Medications

Tailored treatments for specific breeds or diseases offer a lucrative growth avenue. These solutions enhance treatment effectiveness and improve owner satisfaction.

2.Telemedicine Growth

Veterinary telehealth is bridging the gap between pet owners and professionals, enabling faster consultations and online prescription fulfillment.

3.Preventive Care

The emphasis on vaccines and parasite control presents opportunities for growth in preventive healthcare segments.

4.Challenges

1.High Costs

Expensive treatments and medications pose barriers, especially in regions with limited access to pet insurance.

2.Regulatory Hurdles

Varying regulations across regions can slow down drug approvals and market entry for new players.

Competitive Landscape

The market is highly competitive, with major players like Zoetis, Merck Animal Health, Boehringer Ingelheim, and Elanco Animal Health leading innovation. These companies invest heavily in R&D to introduce new products, such as the Zenrelia™ tablets launched by Elanco in 2024 for canine dermatology.

Key Players

Zoetis: Known for its broad product range, including vaccines and anti-infectives.

Elanco Animal Health: Focuses on innovative solutions for dermatology and parasiticides.

Virbac and PetIQ: Emerging players emphasizing accessible healthcare.

High-value mergers and acquisitions characterize the market, enabling companies to expand their offerings and stay competitive.

Recent Developments

1.FDA Approvals

Regulatory approvals for advanced treatments like Zenrelia™ are shaping the market.

2.E-commerce Expansion

Companies are leveraging online platforms to reach a broader audience, especially in emerging markets.

Conclusion

The pet pharmaceuticals market is poised for robust growth, driven by rising pet owPet Pharmaceuticals Market Size, Share & Forecast 2025-2035nership, technological advancements, and increased spending on veterinary care. While challenges like high costs persist, opportunities in personalized medicine and telehealth are paving the way for innovation. With major players leading the charge, the industry is set to transform how pet healthcare is delivered, ensuring a brighter future for pets worldwide. Get sample report https://www.metatechinsights.com/request-sample/1173  for more deatiled insights

[marketanalysisdata]

Animal Wound Care Industry Size, Trends, Statistics and Analysis Report, 2030

The global animal wound care market size is expected to reach USD 1.82 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.92% from 2023 to 2030. Key factors driving the industry growth include the rising adoption of companion animals, increasing pet population, increasing demand for veterinary surgeries, and rising animal injury cases. The global population of companion animals has also increased. In November 2021, the American Veterinary Medical Association (AVMA) reported that the companion animal population increased significantly from 2016 to 2020. As per the article, there were an estimated 76.8 million dogs in 2016 in the U.S., which increased to 83.7 million in 2020.

There was a similar increase in the pet cat population, from 58.4 million in 2016 to 60 million in 2020. As per the European FEDIAF, in 2021, there were nearly 113.5 million cats and 92.9 million dogs in Europe. Thus, the constantly rising pet population and respective adoption rates of dogs & cats are driving the industry. In addition, animals like dogs are more likely to sustain minor or major injuries. Accidental trauma to dogs is one of the more frequent types of injury incidents that are documented. Major trauma, such as bone fractures, internal & external injuries, hemorrhage & organ trauma, joint dislocations, brain trauma, and skin wounds including rashes, are frequently caused by car accidents. In the United States, each year, over 10,000 accidents, involving dogs, are reported, some of which result in damage or even the death of animals.

Gather more insights about the market drivers, restrains and growth of the Global Animal Wound Care Market

The U.S. Department of Transportation estimates that each year, over 1 million animals pass away on roads. On the other hand, dog fights or attacks can cause severe wounds in the skin and soft tissues, as the teeth can puncture deep into the underlying tissues, muscles, and organ walls. Untrained pets are more likely to get cuts, scrapes, and minor wounds frequently. Animals get injured in various scenarios, which can be severe and require immediate veterinary wound care for stitches, infection prevention, etc. Thus, with the increasing pet adoption and animal population globally, the demand for veterinary wound care & surgeries is also rising. This is expected to boost industrial development. Moreover, rising disposable income is expected to fuel the market growth during the forecast period.

Animal Wound Care Market Report Highlights

The companion animal segment held a dominant revenue share in 2022 owing to the high pet adoption & humanization trends and growing pet healthcare expenditure

The surgical wound care product segment is expected to dominate the industry over the forecast period due to rising usage of skin staplers due to their benefits including ease of use, shorter surgical times, and simplicity of removal

The veterinary hospitals & clinics segment held the largest revenue share in 2022 owing to the benefits, such as faster diagnosis and easy access & availability of various treatments in these settings

North America is expected to remain dominant throughout the forecast period due to an increase in efforts by major players to advance their product portfolios by guaranteeing high-quality standards

Browse through Grand View Research's Animal Health Industry Research Reports.

ASEAN Rabies Veterinary Vaccines Market: The ASEAN rabies veterinary vaccines market size was estimated at USD 31.71 million in 2024 and is projected to grow at a CAGR of 6.73% from 2025 to 2030.

Johne's Disease Diagnostics Market: The global Johne’s disease diagnostics market size was estimated at USD 699.5 million in 2024 and is projected to grow at a CAGR of 6.21% from 2025 to 2030.

Animal Wound Care Market Segmentation

Grand View Research has segmented the global animal wound care market on the basis of product, animal type, end-use, distribution channel, and region:

Animal Wound Care Product Outlook (Revenue, USD Million, 2018 - 2030)

Surgical Wound Care Products

Sutures & Staplers

Tissue Adhesive

Advanced Wound Care Products

Foam Dressings

Hydrocolloid Dressing

Film Dressing

Hydrogel Dressing

Others

Traditional Wound Care Products

Tapes

Bandages

Dressing

Absorbents

Others

Therapy Devices

Animal Wound Care Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

Companion Animals

Dogs

Cats

Horses

Others

Livestock Animals

Animal Wound Care End-use Outlook (Revenue, USD Million, 2018 - 2030)

Veterinary Hospitals/Clinics

Homecare

Research Institutes

Animal Wound Care Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

Retail

E-commerce

Veterinary Hospitals/Clinics

Animal Wound Care Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

MEA

Order a free sample PDF of the Animal Wound Care Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

Animal Wound Care Industry Trends, Size, Revenue And Top Key Players, 2030

The global animal wound care market size is expected to reach USD 1.82 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.92% from 2023 to 2030. Key factors driving the industry growth include the rising adoption of companion animals, increasing pet population, increasing demand for veterinary surgeries, and rising animal injury cases. The global population of companion animals has also increased. In November 2021, the American Veterinary Medical Association (AVMA) reported that the companion animal population increased significantly from 2016 to 2020. As per the article, there were an estimated 76.8 million dogs in 2016 in the U.S., which increased to 83.7 million in 2020.

There was a similar increase in the pet cat population, from 58.4 million in 2016 to 60 million in 2020. As per the European FEDIAF, in 2021, there were nearly 113.5 million cats and 92.9 million dogs in Europe. Thus, the constantly rising pet population and respective adoption rates of dogs & cats are driving the industry. In addition, animals like dogs are more likely to sustain minor or major injuries. Accidental trauma to dogs is one of the more frequent types of injury incidents that are documented. Major trauma, such as bone fractures, internal & external injuries, hemorrhage & organ trauma, joint dislocations, brain trauma, and skin wounds including rashes, are frequently caused by car accidents. In the United States, each year, over 10,000 accidents, involving dogs, are reported, some of which result in damage or even the death of animals.

Gather more insights about the market drivers, restrains and growth of the Global Animal Wound Care Market

The U.S. Department of Transportation estimates that each year, over 1 million animals pass away on roads. On the other hand, dog fights or attacks can cause severe wounds in the skin and soft tissues, as the teeth can puncture deep into the underlying tissues, muscles, and organ walls. Untrained pets are more likely to get cuts, scrapes, and minor wounds frequently. Animals get injured in various scenarios, which can be severe and require immediate veterinary wound care for stitches, infection prevention, etc. Thus, with the increasing pet adoption and animal population globally, the demand for veterinary wound care & surgeries is also rising. This is expected to boost industrial development. Moreover, rising disposable income is expected to fuel the market growth during the forecast period.

Animal Wound Care Market Report Highlights

The companion animal segment held a dominant revenue share in 2022 owing to the high pet adoption & humanization trends and growing pet healthcare expenditure

The surgical wound care product segment is expected to dominate the industry over the forecast period due to rising usage of skin staplers due to their benefits including ease of use, shorter surgical times, and simplicity of removal

The veterinary hospitals & clinics segment held the largest revenue share in 2022 owing to the benefits, such as faster diagnosis and easy access & availability of various treatments in these settings

North America is expected to remain dominant throughout the forecast period due to an increase in efforts by major players to advance their product portfolios by guaranteeing high-quality standards

Browse through Grand View Research's Animal Health Industry Research Reports.

ASEAN Rabies Veterinary Vaccines Market: The ASEAN rabies veterinary vaccines market size was estimated at USD 31.71 million in 2024 and is projected to grow at a CAGR of 6.73% from 2025 to 2030.

Johne's Disease Diagnostics Market: The global Johne’s disease diagnostics market size was estimated at USD 699.5 million in 2024 and is projected to grow at a CAGR of 6.21% from 2025 to 2030.

Animal Wound Care Market Segmentation

Grand View Research has segmented the global animal wound care market on the basis of product, animal type, end-use, distribution channel, and region:

Animal Wound Care Product Outlook (Revenue, USD Million, 2018 - 2030)

Surgical Wound Care Products

Sutures & Staplers

Tissue Adhesive

Advanced Wound Care Products

Foam Dressings

Hydrocolloid Dressing

Film Dressing

Hydrogel Dressing

Others

Traditional Wound Care Products

Tapes

Bandages

Dressing

Absorbents

Others

Therapy Devices

Animal Wound Care Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

Companion Animals

Dogs

Cats

Horses

Others

Livestock Animals

Animal Wound Care End-use Outlook (Revenue, USD Million, 2018 - 2030)

Veterinary Hospitals/Clinics

Homecare

Research Institutes

Animal Wound Care Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

Retail

E-commerce

Veterinary Hospitals/Clinics

Animal Wound Care Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

MEA

Order a free sample PDF of the Animal Wound Care Market Intelligence Study, published by Grand View Research.

[jayanthitbrc]

Veterinary Rapid Test Market Expansion 2024-2033: Growth Drivers and Dynamics

The veterinary rapid test global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Veterinary Rapid Test Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The veterinary rapid test market size has grown rapidly in recent years. It will grow from $0.72 billion in 2023 to $0.80 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to growth in veterinary rapid tests, rise in demand for rapid test diagnosis over other test, rise in adoption of pet insurance, increased demand for animal-based protein source, rise in numbers of veterinarians and veterinary visits.

The veterinary rapid test market size is expected to see rapid growth in the next few years. It will grow to $1.24 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing pet ownership, increasing consumer awareness regarding scientific animal nutrition, increase in industrialized livestock production, increasing diagnostic testing of livestock diseases, increasing prevalence of zoonotic diseases in animals. Major trends in the forecast period include product innovation, advancements in biotechnology, demand for quick and accurate diagnostic solutions, innovative veterinary diagnostics, technological advancements in diagnostic technologies.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/veterinary-rapid-test-global-market-report

Scope Of Veterinary Rapid Test MarketThe Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Veterinary Rapid Test Market Overview

Market Drivers -The increasing pet ownership is expected to propel the growth of the growth of the veterinary rapid test market going forward. Pet ownership refers to the relationship in which an individual or household takes responsibility for a pet animal's care, welfare, and maintenance. The increase in pet ownership can be attributed to social trends, urbanization, and a rise in young adults delaying parenthood. Veterinary rapid tests provide pet owners with timely and accurate diagnostic information, facilitating proactive healthcare management and ultimately promoting their animal companions' health, happiness, and longevity. For instance, according to The American Pet Products Association (APPA), a US-based organization, pet ownership in the United States rose from 67% of households owning a pet in 2021-2022 to 70%. Additionally, from 2023 to 2024, 66% of U.S. households owned a pet, which equates to 86.9 million households. Therefore, increasing pet ownership drives the veterinary rapid test market.

Market Trends - Major companies operating in the veterinary rapid test market are developing advanced solutions such as AI-based rapid tests to enhance diagnostic accuracy and improve overall efficiency in veterinary healthcare. AI-based rapid tests represent a significant advancement in veterinary diagnostics, offering veterinarians powerful tools to expedite the diagnostic process, improve diagnostic accuracy, and ultimately enhance the quality of care provided to animals. For instance, in November 2023, Micron Agritech, an Ireland-based sustainable health company, launched the Micron Kit Fluke Test, an innovative AI-powered rapid test for liver fluke in livestock. This breakthrough solution allows farmers and veterinarians to quickly test animals on-site using their smartphones for both liver fluke (Fasciola hepatica) and rumen fluke (Calicophoron daubneyi) infections

The veterinary rapid test market covered in this report is segmented –

1) By Product: Rapid Test Kits, Rapid Test Readers 2) By Animal Type : Companion Animal, Production Animal 3) By Technology : Immunoassays, Polymerase Chain Reaction(PCR) 4) By Application: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies, Other Applications 5) By End-User: Veterinary Hospitals And Clinics, Homecare Settings, Other End Users

Get an inside scoop of the veterinary rapid test market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15956&type=smp

Regional Insights - North America was the largest region in the veterinary rapid test market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies - Major companies operating in the veterinary rapid test market are Thermo Fisher Scientific Inc., Zoetis Inc., bioMérieux SA, IDEXX Laboratories Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN GmbH, Virbac Corp., Neogen Corporation , Antech Diagnostics Inc., Heska Corporation, Ring Biotechnology Co Ltd., Woodley Equipment Company Ltd., Prometheus Biosciences Inc., BioChek, Bionote Usa Inc., Agrolabo S.p.A., Shenzhen Bioeasy Biotechnology Co. Ltd., Fassisi GmbH, MEGACOR Diagnostik GmbH, Biopanda Reagents Ltd., Boster Biological Technology Co. Ltd., Swissavans AG, Secure Diagnostics Pvt. Ltd., Eurolyser Diagnostica GmbH

Table of Contents 1. Executive Summary 2. Veterinary Rapid Test Market Report Structure 3. Veterinary Rapid Test Market Trends And Strategies 4. Veterinary Rapid Test Market – Macro Economic Scenario 5. Veterinary Rapid Test Market Size And Growth ….. 27. Veterinary Rapid Test Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[deshpandeisha]

The Growing Field of Animal Ultrasound: A Game Changer in Veterinary Medicine

The global animal ultrasound market size reached USD 286.2 Million in 2020 and is expected to register a revenue CAGR of 8.2% during the forecast period, according to latest analysis by Emergen Research. Increasing number of companion animals and rising demand for pet insurance are some key factors projected to support market revenue growth between 2021 and 2028.

In addition, increasing number of veterinary doctors in developed and developing countries is expected to boost revenue growth of the market going ahead.Increasing number of veterinarians has also resultedin increasingnumberof new treatment facilities, which is expected to boost demand for various treatmentequipment for animals, including animal ultrasound devices.In addition, veterinarians' incomes in developed countries have significantly risen in recent years, and this is strengthening their purchasing power, which is expected to boostadoption of animalultrasound devices in private clinics.

Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/866

Competitive Terrain:

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Animal Ultrasound market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

The leading market contenders listed in the report are:

IDEXX Laboratories, Inc., Carestream Health, Inc., Fujifilm Holdings Corporation, Esaote SpA, GE Healthcare, Heska Corporation, Diagnostic Imaging Systems, Inc., Clarius Mobile Health Corp., DRAMIÑSKI S.A., and Hallmarq Veterinary Imaging Limited

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/animal-ultrasound-market

Emergen Research has segmented the global Animal Ultrasound market on the basis of type, application, end-use, and region:

Segments Covered in this report are:

Animal Type Outlook (Revenue, USD Million; 2018–2028)

Large Animals

Small Companion Animals

Imaging Type Outlook (Revenue, USD Million; 2018–2028)

Doppler Imaging

2D Ultrasound Imaging

3D & 4D Ultrasound Imaging

Scanner Type Outlook (Revenue, USD Million; 2018–2028)

Handheld Ultrasound Scanners

Cart-based Ultrasound Scanners

The various regions analyzed in the report include:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Objectives of the Report:

Analysis and estimation of the Animal Ultrasound Market size and share for the projected period of 2022-2030

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Animal Ultrasound Market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/866

[market-insider]

Veterinary Hospitals Market Dynamics: Evaluating Market Size, Share, and Growth Forecast

The global veterinary hospitals market size is expected to reach USD 123.8 billion by 2030, expanding at a CAGR of 5.80% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growing pet population is boosting the demand for veterinary clinics and hospitals around the world. Additionally, the COVID-19 pandemic lockdown restrictions led to a rise in the demand for companion animals. For instance, the number of pets in the UK has significantly increased. According to a recent survey conducted by the Pet Food Manufacturers Association, there are currently over 24 million cats and dogs living in the United Kingdom. The market is being driven by the increase in pet ownership, not just in the short term when kittens and puppies need shots, initial checkups, or neutering, but also considerably in the long term as they age into animals needing more veterinarian treatment and care.

Veterinary Hospitals Market Report Highlights

By animal type, the companion animal segment accounted for the largest revenue share in 2022. This is owing to the relatively stable ownership rate of dogs & cats in developed countries like the U.S. and increased expenditure on veterinary care

Based on type, the medicine segment dominated the market in 2022, owing to its significant distribution in veterinary pharmacies

Based on the sector, the private segment dominated the market in 2022. These hospitals offer well-maintained and advanced services at a relatively low price than private hospitals

North America accounted for a 43.4% share of the market in 2022 and is expected to grow over the forecast period. This growth is majorly due to high companion animal ownership rates, favorable government regulations, and increasing adoption of pet insurance for veterinary care

For More Details or Sample Copy please visit link @: Veterinary Hospitals Market Report

The rapidly aging pet population and the availability of advanced pet care options are among the key factors likely to drive expenditure on pets by owners, which is the primary source of revenue growth for veterinary hospitals. Establishment requirements for veterinary hospitals are expected to improve mainly due to the high demand for animal care services for pets & animals food. With the increasing number of pets and pet owners, the focus on animal safety has grown in recent years. Rising concerns and increasing awareness about chronic diseases in companion animals have resulted in high expenditure on pet health. Large spending on animal care is expected to further boost veterinary visits and medication sales in hospitals. Owners are concerned about their pets and consult veterinarians for treatment of several health issues at an early stage. This is further boosting the demand for efficient treatment options, driving the market.

[industryinsightsandanalysis]

Veterinary Point of Care Diagnostics Market Size, Share, Growth and Forecast (2021-2027)

The Global Veterinary Point of Care Diagnostics Market is anticipated to grow significantly by 2027, with an estimated CAGR of around 12% during the forecast period from 2021 to 2027. Point-of-care diagnostics (POCD) have become crucial in the healthcare sector for their ability to rapidly diagnose various life-threatening and infectious diseases such as cancer and diabetes, as well as for ongoing patient health monitoring. These devices are seen as essential diagnostic tools that help prevent treatment delays, thereby reducing mortality rates and the spread of infectious agents.

Key Growth Drivers

A major factor driving the veterinary industry's growth is the increasing adoption of pets. Additionally, the rise in diseases affecting animals contributes to the expanding veterinary point-of-care diagnostics market. For instance, according to Vikaspedia (Government of India), the country's total livestock population was 535.78 million in 2019, marking a 4.6% increase since the 2012 Livestock Census. The bovine population (including cattle, buffalo, mithun, and yak) reached 302.79 million in 2019, a 1.0% increase from the previous census. Furthermore, the growing number of zoological parks and heightened efforts in animal conservation significantly influence the demand for point-of-care diagnostics in veterinary medicine.

For a comprehensive analysis of the market drivers, visit: https://univdatos.com/report/veterinary-point-of-care-diagnostics-market/

Market Segmentation

By Animal Type

The market is divided into two main segments: livestock and companion animals. The livestock segment is expected to witness significant growth, driven by the increasing cattle population and the adoption of modern technologies for animal care. For instance, the Department of Animal Husbandry and Dairying (Government of India) reported that the female cattle population reached 145.12 million in 2019, an 18.0% increase since 2012.

By End-Users

The market is segmented into veterinary hospitals & clinics, home care settings, and others. The veterinary hospitals & clinics segment is projected to experience substantial growth due to rising pet adoption, the prevalence of diseases, and increasing health concerns among pet owners. The specialized services offered by these hospitals and clinics further bolster the segment's growth in the veterinary point-of-care diagnostics market.

Regional Insights

The report also provides a detailed regional analysis of the veterinary point-of-care diagnostics market, covering North America (United States, Canada, Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, Rest of Europe), Asia-Pacific (China, India, Australia, Japan, Rest of APAC), and the Rest of the World. North America represents a significant market due to the high rate of pet adoption. According to the American Pet Products Association (APPA), 67% of U.S. households owned pets in 2021, with total expenditure on pet care products estimated at $123.6 billion.

For a sample report, visit: https://univdatos.com/get-a-free-sample-form-php/?product_id=22912

Key Market Players

Prominent companies in the global veterinary point-of-care diagnostics market include IDEXX Laboratories, Zoetis, Virbac, Heska Corporation, Thermo Fisher Scientific Inc., Neogen Corporation, Mindray, Esaote SpA, FUJIFILM Corporation, and Woodley Equipment Company Ltd. These players have engaged in numerous mergers and acquisitions, as well as partnerships, to develop various veterinary point-of-care diagnostics solutions.

Contact Us:

UnivDatos Market Insights

Email - contact@univdatos.com

Contact Number - +1 9782263411

Website -www.univdatos.com

[industryforecastnews]

U.S. Veterinary Orthopedic Medicine Market Size, Share & Growth Analysis Report, 2030

U.S. Veterinary Orthopedic Medicine Market Growth & Trends

The U.S. veterinary orthopedic medicine market size is expected to reach USD 814.51 million by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing pet population, adoption of pet insurance, rising prevalence of diseases among animals, and advancements in veterinary medicine.

For instance, in October 2023, the FDA approved Librela (bedinvetmab injection), making it the first monoclonal antibody for treating osteoarthritis-related pain in dogs. In addition, in April 2022, American Regent Animal Health, a division of American Regent, Inc., received FDA approval to extend the shelf life of Adequan Canine and Adequan i.m. The expiration date for both products was increased from 24 months to 36 months from the date of manufacture.

Key players in the veterinary orthopedic medicine market are engaging in strategic initiatives like product launches, collaborations, and acquisitions to make their market presence more prominent, impelling market growth. In September 2022, Zoetis acquired Jurox, a private animal health company specializing in veterinary medicines for livestock and companion animals. The deal, finalized in August 2021, included Jurox's operations in Australia and regional offices in the U.S., Canada, and the UK. Such initiatives are anticipated to drive market growth.

For instance, in October 2023, Athersys, Inc. (ATHX), a cell therapy and regenerative medicine company, entered into a licensing agreement with Ardent Animal Health. With this move, Athersys, known for its work with MultiStem (invimestrocel) in critical care, entered the field of animal health. This collaboration with Ardent, a veterinary biotech firm specializing in regenerative medicine and cancer therapies for animals, highlights Athersys’ commitment to advancing veterinary care.    

Some key impacts of the pandemic and respective lockdowns on the market include dampened growth, decreased sales, supply chain disruptions, and operational challenges. However, the pandemic also propelled concerns over animal health and welfare, strengthened the pet parent and animal bond, and increased pet adoption. Moreover, the market witnessed an improved medicalization rate, pet expenditure, and adoption of pet insurance.

Increasing pet humanization and improved diagnostic rates were other positive impacts of the COVID-19 pandemic on the veterinary sector. In 2021, the market recorded increased demand and sale of veterinary medicines, including orthopedic medicines. In 2022, other macroeconomic uncertainties, such as global recession and cost inflation, adversely impacted the business. However, as the underlying market drivers remain unchanged owing to an increasing prevalence of orthopedic disorders in dogs and horses, the market is estimated to grow notably over the forecast period.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

U.S. Veterinary Orthopedic Medicine Market Report Highlights

Based on product, pharmaceuticals segment dominated the market, accounting for a share of 46.72% in 2023. Pharmaceutical treatments for orthopedic diseases in pets, such as Non-steroidal Anti-inflammatory Drugs (NSAIDs) and pain relievers, have been widely used and established as effective treatments for managing pain and inflammation. On the other hand, the viscosupplements segment is anticipated to grow at the fastest CAGR of 8.23% during the forecast period

Based on animal type, the market is segmented into dogs and horses. The dogs segment dominated the market, accounting for a share of 51.98% in 2023. It is also anticipated to grow at the fastest CAGR of 7.80% in the coming decade

Based on application, the osteoarthritis segment accounted for the largest share of 60.65% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 9.39% over the forecast period

Based on route of administration, the market is segmented into injectable, oral, and others (e.g., topical). The injectable segment dominated the market, accounting for a share of 60.40% in 2023. The others (e.g., topical) segment is anticipated to grow at the fastest CAGR of 8.22% in the coming decade

On the basis of end-use, veterinary clinics & hospitals segment accounted for the largest share of 53.59% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 8.68% over the forecast period

U.S. Veterinary Orthopedic Medicine Market Segmentation

Grand View Research has segmented the U.S. veterinary orthopedic medicine market based on product, animal type, application, route of administration, and end-use:

U.S. Veterinary Orthopedic Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

Biologics

Stem Cells

Platelet-Rich Plasma (PRP)

Other Biologics

Viscosupplements

Pharmaceuticals

Steroids

NSAIDS

Others

U.S. Veterinary Orthopedic Medicine Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

Dogs

Small Breeds

Medium Breeds

Large Breeds

Horses

U.S. Veterinary Orthopedic Medicine Application Outlook (Revenue, USD Million; 2018 - 2030)

Osteoarthritis

Degenerative Joint Disease

Others

U.S. Veterinary Orthopedic Medicine Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

Injectable

Intra-Muscular

Intra-Articular

Others

Oral

Others

U.S. Veterinary Orthopedic Medicine End-use Outlook (Revenue, USD Million, 2018 - 2030)

Veterinary Hospitals & Clinics

At-home

Others

List of Key Players in the U.S. Veterinary Orthopedic Medicine Market

Zoetis Services LLC

Ardent Animal Health, LLC

Enso Discoveries

VetStem, Inc.

Contura Vet

PetVivo Holdings, Inc.

T-Cyte Therepeutics

Boehringer Ingelheim International GmbH

Arthrex, Inc.

MEDREGO LLC

Nucleus ProVets

Daiichi Sankyo Company, Limited 

Bimeda U.S.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

[allbdjobscircular]

World Wide Cat Market Research (Cat Housing, Cat Food, Cat Toys, Cat Grooming and cat treat)

In this video, I have tried to explain a statistic of businesses that have been built around cats. Also in the video, you will notice the different behaviors of the cat. Where a cat is meant to be friendly. Also, the funny activities of cats can always make you happy. About of Cat : 1. Appearance: Cats have a sleek and agile appearance, with sharp retractable claws, keen senses, and a flexible body. They come in various colors, patterns, and fur lengths, which can range from short to long and can be solid or multi-colored. 2. Behavior: Cats are known for their independent and often aloof behavior. They are known to be agile hunters and excellent climbers. They use their sharp senses of sight, hearing, and smell to locate prey and navigate their environment. 3. Domestication: Cats were originally domesticated in ancient Egypt around 4,000 years ago. Since then, they have become popular pets worldwide. Domestic cats are valued for their companionship and their ability to control pests like rodents. 4. Communication: Cats communicate through a combination of vocalizations, body language, and scent marking. They can purr when content, meow to get attention, hiss when threatened, and use their tails and ears to express their emotions. 5. Lifespan: The average lifespan of a domestic cat ranges from 12 to 18 years, although many live longer with proper care. Some breeds are prone to specific health issues, so regular veterinary check-ups are important. 6. Social Structure: Cats are typically solitary animals, but they can be social and form relationships with other cats, as well as with humans. They may establish hierarchies when living together. 7. Grooming: Cats are known for their meticulous grooming habits. They use their rough tongues to clean themselves and keep their fur in good condition. 8. Playfulness: Cats are playful animals and often enjoy interactive toys, hunting games, and physical activities. Play is not only fun for them but also serves as a way to exercise and sharpen their hunting skills. Cats have earned a special place in the hearts of many people due to their charming personalities, diverse appearances, and their ability to form strong bonds with their human companions. They continue to be one of the most popular and beloved pets worldwide. How big is the cat food market? The Cat Food Market size is estimated at USD 34.11 billion in 2023 and is expected to reach USD 44.15 billion by 2028, growing at a CAGR of 5.30% during the forecast period (2023-2028). How big is the cat toy market? The global cat toys market size is forecasted to be appraised at US$ 1,840 million by 2033, up from US$ 1,015.1 million in 2023, advancing at a CAGR of 6.1% during the forecast period. How many cats are there in 2023? There are more than 58 million pet cats in America and anywhere between 30 million and 100 million self-sufficient feral cats roaming American streets. 25.4% of households in America own cats. How big is the pet industry? The global pet care market size was valued at USD 235.32 billion in 2022 and is projected to grow from USD 246.66 billion in 2023 to USD 368.88 billion by 2030, exhibiting a CAGR of 5.92% during the forecast period. Pets are considered members of the family among a vast majority of pet owners. How popular are cats? Dogs are the most popular pets in the U.S. (65.1 million U.S. households own a dog), followed by cats (46.5 million households). #cat #cats #catlover #catvideos #catvideo #pets #marketresearch #worldwide

[global-research-report]

Veterinary Biomarkers Market Report: Opportunities and Challenges in Diagnostics

The global veterinary biomarkers market size is expected to reach USD 2.04 billion by 2030, expanding at 12.61% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The key drivers for the market growth are the increasing prevalence of numerous acute and chronic disorders among animals coupled with the growing demand for better & accurate diagnostic and monitoring technologies. According to the American Veterinary Medical Association, almost half of the dog population is developing cancer at the same rate as humans. This supports the requirement for biomarker-based specific diagnostic kits for timely disease predictions and treatments.

The COVID-19 pandemic created barriers and challenges in the global animal health industry that include decreased marketing & sales activities, low veterinary clinic admission, cancellation of routine pet check-ups, and a low number of disease diagnostic tests performed in veterinary hospitals. However, governments and veterinary organizations of various countries implemented strategies and safety measures to resume veterinary practices and research during the pandemic. According to the American Veterinary Medical Association, telemedicine services were widely incorporated in veterinary clinics and hospitals to curb the impact of lockdowns. Furthermore, the pet parents were given digital training to use certain diagnostic kits.

The increasing animal care expenditure in both developing and developed economies is a significant opportunity for market growth. According to the American Kennel Club (AKC), pet owners in the U.S. were spending more money on their pet’s wellness and related healthcare products. The American Pet Products Association reported that the overall pet industry sale exceeded USD 140 billion by the end of 2022. In addition, the research and development activity in the upcoming fields, such as biomarkers in the veterinary, has been significantly growing over the last decade. These factors are expected to boost the growth of the market.

Veterinary Biomarkers Market Report Highlights

The veterinary biomarkers industry was estimated to be USD 797.3 million in 2022 and is expected to have lucrative growth at a CAGR of 12.61% over the forecast period

The companion animals segment is anticipated to dominate with the highest market share based on animal type during the forecast period. This is owing to the growing adoption rates of dogs and cats in global households coupled with the significant prevalence of diseases and accurate diagnostic requirements among them

Based on the product type, the biomarkers, kits & reagents segment has dominated the market in 2022 with a significant share. This is owing to the growing emergence of post-genomic technologies such as transcriptomics, proteomics, and metabolomics which rises the identification of numerous specific biomarkers for novel point-of-care test kit developments

Based on the application, the disease diagnostics segment has dominated the market in 2022 with the highest share. This is owing to the increasing number of biomarker-based diagnostic test kits launched by key players coupled with the enhanced usage of such kits in veterinary clinics and hospitals

The inflammatory & infectious diseases segment held the largest share of about 35% of the market in 2022 by disease type. This is owing to the high prevalence of inflammatory and infectious diseases among companion and production animals, coupled with a significant number of protein indicators identified for the diseases

By region, North America has dominated the market with a share of over 35% in 2022, while the Asia Pacific market is anticipated to grow the fastest in the coming years. The economic, social, and technological advancements in the North American region are boosting the development of veterinary care in its countries

The market is emerging with the presence of major animal health key players such as Merck & Co., Inc.; Zoetis; Virbac; and IDEXX Laboratories, Inc., among others. The implementation of strategic initiatives by companies, such as acquisitions, collaborations, partnerships, and product launches are, greatly contributing to the growth of the market 

Veterinary Biomarkers Market Segmentation

Grand View Research has segmented the global veterinary biomarkers market based on animal type, product type, application, disease type, and region:

Veterinary Biomarkers Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

Companion Animals

Dogs

Cats

Others

Production Animals

Cows

Pigs

Others

Veterinary Biomarkers Product Type Outlook (Revenue, USD Million, 2018 - 2030)

Biomarkers, Kits & Reagents

Biomarker Readers

Veterinary Biomarkers Application Outlook (Revenue, USD Million, 2018 - 2030)

Disease Diagnostics

Preclinical Research

Others

Veterinary Biomarkers Disease Type Outlook (Revenue, USD Million, 2018 - 2030)

Inflammatory & Infectious Diseases

Cardiovascular Diseases

Skeletal Muscle Diseases

Tumor

Others

Veterinary Biomarkers Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Asia Pacific

China

India

Japan

Australia

South Korea

Latin America

Brazil

Mexico

Argentina

MEA

South Africa

Saudi Arabia

Order a free sample PDF of the Veterinary biomarkers Market Intelligence Study, published by Grand View Research.

[alliedcreation]

Pet Care Market Increasing Demand, Emerging Trends, Growth Opportunities and Future scope

 “Pet Care Market by Product Type, Animal Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021–2030,” the global pet care market size is expected to reach $269,497.5 million by 2030 at a CAGR of 6.2% from 2021 to 2030.

The pet care market is experiencing growth owing to increased pet ownership across the globe due to rise in consumers’ disposable income and increase in awareness regarding the health benefits of having a companion. The major factors driving the growth of the global pet care market include rise in trend of nuclear families, rapid humanization of pets, and increase in awareness about pet health. Surge in pet ownership among the millennials and generation Z along with the rapidly penetrating social media and e-commerce platforms across the globe significantly boosts the pet care market growth.

REQUEST FOR FREE SAMPLE :- https://www.alliedmarketresearch.com/request-sample/6877

The outbreak of the COVID-19 pandemic has positively affected the pet care industry due to undermined and unintended consequence of COVID-19 pandemic. The global pet care market was growing at a strong rate before the pandemic due to rise in pet humanization, concerns about animal welfare, and increased spending on animal health and grooming. However, during the lockdown period, people got more concerned about pet health and their own health, resulting in significant adoption of pet food and other care products for pets to stay healthy. Furthermore, certain COVID-19 repercussions and above factors that accelerated the market growth and are expected to sustain this growth during the forecast period.

The e-commerce segment has positively impacted the overall pet products supply chain as the entire pet care industry witnessed a rapid surge in the revenue. These factors are expected to boost the growth of the pet care market during the forecast period.

According to the pet care market analysis, the pet care market is segmented on the basis of product type, animal type, distribution channel, and region. On the basis of product type, the market is categorized into brushes, shower & bath accessories, toothpaste, grooming wipes, shampoos/conditioners, cat litter, pet comb, tick repellent, dry food, wet food, treats & snacks, and others. By animal type, it is segregated into dogs, cats, birds, and others. By distribution channel, it is segmented into supermarkets, e-commerce, specialized pet stores, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Poland, Italy, Russia, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific), and LAMEA (Brazil, Argentina, South Africa, Saudi Arabia, and rest of LAMEA).

REQUEST FOR CUSTOMIZATION :- https://www.alliedmarketresearch.com/request-for-customization/6877

As per the pet care market forecast, by product type, the dry food segment was the dominating segment that accounted for 31.2% of the market share in 2020. This is attributed to the increased demand for the dry food for pets owing to its nutritional and oral benefits. The cat litter is estimated to be the fastest-growing segment owing to the rising adoption of cats in the developed and developing nations. The adoption of cats as pets is higher in the developed markets like North America and Europe.

By animal type, the dogs and the cats were the two most prominent segments in 2020, dogs segment leading the market. However, the cat segment is estimated to outnumber the dogs segment during the forecast period as the cat adoption across the globe is gaining rapid traction.

This is because cats are less expensive, they require less space, cats prefer to stay indoors all the time, and cats don’t make much noises as the dogs do. Therefore, owning a cat as a pet is more convenient than that of dog.

Depending upon the distribution channel, the e-commerce is expected to be the fastest-growing segment during the forecast period. This is attributed to the rising penetration of the e-commerce platforms, surging adoption of smartphones, and improved access to internet. The rising number of online shoppers and growing popularity of specialized online pet products retailers is fostering the market growth.

The key players operating in the global pet care market have adopted various developmental strategies to expand their market share and increase profitability in the market. The key players profiled in this report include Beaphar, B.V., Colgate Palmolive Company, EBOS Group Limited, General Mills, Inc., Heristo AG, Mars, Incorporated, Nestle SA, Pet AG, PetEdge, Petlife International Ltd., Schell & Kampeter, Inc., Thai Union Group Plc, The J.M. Smucker Company, Unicharm Corporation, and Versele-Laga N.V.

BUY NOW :- https://www.alliedmarketresearch.com/checkout-final/e0d17c523e1389ec62528cdd899db955

Key findings of the study

The global pet care market size was valued at $138,270.0 million in 2020, and is estimated to reach $269,497.5 million by 2030, registering a CAGR of 6.2% from 2021 to 2030. By product type, the cat litter segment is estimated to witness the fastest growth, registering a CAGR of 7.9% during the forecast period. In 2020, depending on animal type, the dogs segment was valued at $47,949.3 million, accounting for 34.6% of the global pet care market share. In 2020, the U.S. was the most prominent market in North America, and is projected to reach $58,666.2 million by 2030, growing at a CAGR of 5.3% during the forecast period.

[rohans18]

Companion Animal Ear Infection Treatment Market Market Size, Reports, Demands, Share - Forecast 2029

Global Companion Animal Ear Infection Treatment Market, By Product (Anti-bacterial, Aminoglycosides, Fluoroquinolones, Others), Disease Type (Otitis Externa, Otitis Media, Otitis Interna), Mode of Administration (Topical, Oral, Otic), Animal Type (Dogs, Cats, Others) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

The consistent Companion Animal Ear Infection Treatment Market report analyzes many points that help businesses to solve the toughest questions in less time. The major topics of this business report are global growth trends, market share by manufacturers, market size by type, market size by application, production by region, consumption by region, company profiles, market forecast, value chain and sales channels analysis, opportunities & challenges, threat and affecting factors. The report gives market definition in the form of market driving factors and market restraints which helps estimating the demand of particular product depending on several aspects. Companion Animal Ear Infection Treatment Market survey report studies the global market status and forecast, categorizes the global market size, market value & market volume by key players, type, application, and region.

Key Players

Some of the major players operating in the companion animal ear infection treatment market report are 3M, STERIS plc, Getinge AB, MMM Group, Cantel Medical, MATACHANA GROUP, Ecolab, BELIMED, INC., Cardinal Health, Steelco S.p.A., Reckitt Benckiser Group plc, Metrex Research, LLC., Stryker, B. Braun Melsungen AG, Covalon Technologies Ltd., SKYTRON, LLC, Olympus Corporation of the Americas (A Subsidiary of Olympus Corporation), COLTENE Group, Pal International, MELAG Medizintechnik GmbH & Co. KG, Cisa Production S.r.l. Unipersonale, TERRAGENE SA, The Clorox Company among other

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-companion-animal-ear-infection-treatment-market

One of the principal objectives of a high-ranking Companion Animal Ear Infection Treatment Market industry report is to analyze and study the global sales, value, status, and forecast. The market report also analyzes the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. The report assists to define, describe and forecast the market by type, application and region. It estimates the region that is foretold to create the most number of opportunities in the global Companion Animal Ear Infection Treatment Market. This market research report comprises of estimations of CAGR values which are quite significant and aids businesses to decide upon the investment value over the time period. An insightful Companion Animal Ear Infection Treatment Market report assists clients to stay ahead of the time and competition.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Companion Animal Ear Infection Treatment Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Sizing

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sales@databridgemarketresearch.com